-80%

est. 2Y upside i

HealthcareSeries B

Stage: early. Country: Germany

Rank

#3725

Sector

Connected Fitness, Health & Wellness

Est. Liquidity

~3Y

Data Quality

Data: Low

The equity opportunity for VAHA is highly risky.

Last updated: March 10, 2026

Bull (10%)+300%

VAHA's integration with Bioniq's personalized nutrition platform creates a compelling holistic health offering, driving significant user growth and market share. This synergy could propel the combined entity's valuation to $600M+, representing a substantial increase over VAHA's estimated pre-acquisition value and a strong return for Bioniq equity holders, assuming the VAHA unit is a primary driver of this growth.

Base (45%)+20%

VAHA successfully integrates into Bioniq, maintaining its user base and contributing steadily to Bioniq's revenue growth. However, intense competition from Lululemon Studio and other connected fitness players limits significant expansion, leading to a modest increase in the VAHA unit's implied value to $180M within Bioniq's overall valuation.

Bear (45%)-70%

VAHA's integration into Bioniq faces challenges, and the connected fitness market continues to be dominated by well-funded incumbents like Lululemon Studio. The VAHA unit struggles to grow, leading to a significant write-down of its value within Bioniq, potentially to $45M, severely impacting any equity tied to its performance.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Bioniq has raised $31.1M in total funding against a current valuation of $82M, meaning investors hold $31.1M in liquidation preferences ahead of common shareholders.

Dilution Risk

high

As a Series B company, Bioniq is likely to pursue additional funding rounds, which will lead to further dilution of existing equity holders.

Secondary Liquidity

none

As a privately held company, there is no active secondary market for Bioniq (or former VAHA) equity.

Questions to Ask at the Interview

Strategic questions based on VAHA's data — designed to show you've done your homework.

  • 1

    “Given VAHA's acquisition by Bioniq, how is the company structuring equity compensation for new hires on the VAHA team, and what are the specific mechanisms for how VAHA's performance contributes to that equity value?”

  • 2

    “How is Bioniq planning to differentiate the VAHA offering within the highly competitive connected fitness market, especially against dominant incumbents like Lululemon Studio?”

  • 3

    “With Bioniq's Series B funding and current valuation, what is the anticipated timeline and strategy for a liquidity event (e.g., IPO or further acquisition), and how might that impact employee equity?”

Community

Valuation Sentiment

Our model estimates -80% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.